Adams Law

www.adamslaw.us

Publications 

(selected)

  • Food and Drug Law and Regulation Third Edition (D. Adams, R. Cooper, R. Hahn, J. Kahan, ed.) (FDLI 2015)
  • D. Adams, “Regulation of Healthcare Professionals,” Food and Drug Law and Regulation Third Edition, 667-82 (FDLI 2015)
  • D. Adams, J. Havens, “Tobacco Product Substantial Equivalence Guidance — Take 2,” Law360 (October 7, 2015)
  • D. Adams, T. Harrison, R. Tyler, J. Moore, “FDA Issues Proposed Rule to Clarify When Products Made or Derived From Tobacco Are Regulated as Drugs, Devices, or Combination Products,” Venable LLP (September 25, 2015)
  • D. Adams, A. Craig, T. Harrison, R. Tyler, “FDA Issues Second Edition of New Tobacco Product Substantial Equivalence Guidance,” Venable LLP (September 10, 2015)
  • D. Adams, S. Abramson, K. Klesh, “FDA Issues Draft Guidance on Promotion on Internet and Social Media Platforms,” Venable LLP (June 2014)
  • D. Adams, T. Harrison, C. Lewis, R. Tyler, M. Jackson, “FDA Serves Up Another Helping of Draft Guidance on Medical Foods,” Venable LLP (Aug. 2013)
  • D. Adams, T. Harrison, C. Lewis, R. Tyler, “Second Circuit Rules Off-Label Marketing is Protected by First Amendment,” Venable LLP (December 2012)
  • Food and Drug Law and Regulation Second Edition (D. Adams, R. Cooper, R. Hahn, J. Kahan, ed.) (FDLI 2011)
  • D. Adams, “Regulation of Healthcare Professionals,” Food and Drug Law and Regulation Second Edition, 705-20 (FDLI 2011)
  • Food and Drug Law and Regulation (D. Adams, R. Cooper, R. Hahn, J. Kahan, ed.) (FDLI 2008)
  • D. Adams, “Regulation of Healthcare Professionals,” Food and Drug Law and Regulation, 571-86 (FDLI 2008)
  • D. Adams, “A Two-Cigarette Society,” The New York Times (October 22, 2007)
  • D. Adams, “Essential Elements of FDA Practice and Strategy,” Best Practices for Food and Drug Law (Aspatore 2005)
  • D. Adams, R. Cooper, J. Kahan, ed, Fundamentals of Law and Regulation (Supplement): The FDA Modernization Act (FDLI 1999)
  • D. Adams, “Regulation of Healthcare Professionals,” Fundamentals of Law and Regulation (Supplement): The FDA Modernization Act (FDLI 1999)
  • D. Adams, R. Cooper, J. Kahan, ed, Fundamentals of Law and Regulation Vol. II (FDLI 1997)
  • D. Adams, N. Beaver, “Key Provisions of the Food and Drug Modernization Act of 1997 Relating to Drugs and Biologics, Fundamentals of Law and Regulation Vol. II, 29-62 (FDLI 1997)
  • D. Adams, “Regulation of Healthcare Professionals,” Fundamentals of Law and Regulation Vol. II, 423-436 (FDLI 1997)
  • D. Adams, "USPTO and FDA Rulings Limit Uruguay Round Agreements Act Benefits and Protections for Certain Patents on FDA-Regulated Products," 136 Legal Mind 731 (1995)
  • D. Adams, "FDA's Final Regulations on Generic Drug Approval:  Marketing Exclusivity," 131 Legal Mind 59 (1995)
  • D. Adams, "FDA's Final Regulations on Generic Drug Approval:  Patent Protections, Patent Challenges," 128 Legal Mind 66 (1994)
  • D. Adams, "FDA Regulation of Communications on Pharmaceutical Products," 24 Seton Hall L. Rev. 1399 (1994)
  • D. Adams, "FDA Policy on Industry-Supported Scientific and Educational Activities," 47 Food and Drug Law Journal 624 (1993)
  • D. Adams, "Pharmaceutical Advertising:  Education versus Promotion," 7 J. of Pharmaceutical Marketing and Management 53 (1992), reprinted in Promotion of Pharmaceuticals, D. Pathak Ed. (1992)